“Therefore, toxicology studies were conducted using a transgenic mouse model expressing human CD19 (huCD19 Tg).”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗
Why that species
Binds human CD19 only; no cross-reactivity with nonhuman primate, rodent or rabbit CD19
“Inebilizumab binds specifically to human CD19 and shows no cross-reactivity for CD19 in nonhuman primate, rodents, or rabbits. Therefore, the species selected for nonclinical testing was the human CD19 transgenic mouse model (huCD19 Tg), which was considered the only relevant species.”
✓ VerifiedFDA pharmacology/toxicology review, p. 11Source ↗
Surrogate molecule
Yes: human CD19 transgenic (huCD19 Tg) mouse model, used for all general, fertility/EFD and PPND toxicology studies
“The pivotal nonclinical studies were conducted in a transgenic mouse (hCD19Tg) model that expresses human CD19 because inebilizumab is not pharmacologically active in rodent (mouse, rat) or nonrodent (rabbit, monkey).”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗